EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase

Suowen Xu, Xiumei Wu, Sichen Wang, Mengyun Xu, Tingyu Fang, Xiaoxuan Ma, Meijie Chen, Jiajun Fu, Juan Guo, Song Tian, Tian Tian, Xu Cheng und 12 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci166149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Suowen Xu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medi…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsMiceArtificial IntelligenceDiet, High-FatFatty Acid SynthasesFatty Acid Synthase, Type I

Stichwörter der Autor:innen

HepatologyUbiquitin-proteosome system

Substanzen

Fatty Acid SynthasesFasn protein, mouseFatty Acid Synthase, Type I

Autor:innen und Institutionen

  • Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of the Chinese Academy of Sciences (H…
  • Department of Endocrinology, Guangdong Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • School of Basic Medical Sciences, Wuhan University, Wuhan, China.
  • State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute and.
  • School of Medical Information Engineering, Gannan Medical University, Gannan Medical University, Ganzhou, China.

Förderung

  • National Key R&D Program of China

Zitieren

APA

Xu, S., Wu, X., Wang, S., Xu, M., Fang, T., Ma, X., Chen, M., Fu, J., Guo, J., Tian, S., Tian, T., Cheng, X., Yang, H., Zhou, J., Wang, Z., Yin, Y., Xu, W., Xu, F., Yan, J., …, & Weng, J. (2024). TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. Journal of Clinical Investigation. https://doi.org/10.1172/jci166149

Vancouver

Xu S, Wu X, Wang S, Xu M, Fang T, Ma X, et al. TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. Journal of Clinical Investigation. 2024. doi:10.1172/jci166149

BibTeX
@article{Xu2024,
  author = {Xu, Suowen and Wu, Xiumei and Wang, Sichen and Xu, Mengyun and Fang, Tingyu and Ma, Xiaoxuan and Chen, Meijie and Fu, Jiajun and Guo, Juan and Tian, Song and Tian, Tian and Cheng, Xu and Yang, Hailong and Zhou, Junjie and Wang, Zhenya and Yin, Yanjun and Xu, Wen and Xu, Fen and Yan, Jinhua and Wang, Zhihua and Luo, Sihui and Zhang, Xiao-Jing and Ji, Yan-Xiao and Weng, Jianping},
  title = {TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci166149}
}
Kostenlos starten →